UAB Digital Repository of Documents 1 records found  Search took 0.03 seconds. 
1.
13 p, 2.9 MB Genomic profiling of NETs : A comprehensive analysis of the RADIANT trials / Yao, James (University of Texas MD Anderson Cancer Center) ; Garg, Amit (Novartis Institutes for Biomedical Research) ; Chen, David (Novartis Pharmaceuticals Corporation) ; Capdevila Castillón, Jaume (Vall d'Hebron Institut d'Oncologia) ; Engstrom, Paul (Fox Chase Cancer Center) ; Pommier, Rodney (Oregon Health and Science University) ; Van Cutsem, Eric (University Hospitals Gasthuisberg (Leuven, Bélgica)) ; Singh, Simron (Odette Cancer Center. Sunnybrook Health Sciences Center) ; Fazio, Nicola (European Institute of Oncology) ; He, Wei (Novartis Pharmaceuticals Corporation) ; Riester, Markus (Novartis Institutes for Biomedical Research) ; Patel, Parul (Novartis Pharmaceuticals Corporation) ; Voi, Maurizio (Novartis Pharmaceuticals Corporation) ; Morrissey, Michael (Novartis Institutes for Biomedical Research) ; Pavel, Marianne (University of Erlangen-Nuremberg) ; Helmut Kulke, Matthew. (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica)) ; Universitat Autònoma de Barcelona
Neuroendocrine tumors (NETs) have historically been subcategorized according to histologic features and the site of anatomic origin. Here, we characterize the genomic alterations in patients enrolled in three phase 3 clinical trials of NET of different anatomic origins and assess the potential correlation with clinical outcomes. [...]
2018 - 10.1530/ERC-18-0332
Endocrine-Related Cancer, Vol. 26 Núm. 4 (2018), p. 391-403  

Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.